Charcot-Leyden crystals
Charcot-Leyden crystals | |
---|---|
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Asthma, Eosinophilia |
Complications | Respiratory distress |
Onset | Variable |
Duration | Chronic |
Types | N/A |
Causes | Eosinophil breakdown |
Risks | Allergic reactions, Parasitic infections |
Diagnosis | Microscopic examination |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Management of underlying condition |
Medication | N/A |
Prognosis | Depends on underlying cause |
Frequency | N/A |
Deaths | N/A |
Charcot-Leyden crystals are microscopic crystals found in people who have diseases associated with eosinophilia, such as asthma and certain parasitic infections. These crystals are formed from the breakdown of eosinophils, a type of white blood cell involved in the body's immune response.
History[edit | edit source]
Charcot-Leyden crystals were first described by Jean-Martin Charcot and Ernst Viktor von Leyden in the 19th century. They are named after these two scientists who contributed significantly to the study of neurology and hematology.
Structure[edit | edit source]
Charcot-Leyden crystals are elongated and bipyramidal in shape. They are composed of a protein called galectin-10, which is released during the breakdown of eosinophils. These crystals are typically colorless and can be observed under a microscope in sputum, feces, or tissue samples.
Clinical Significance[edit | edit source]
The presence of Charcot-Leyden crystals is often associated with conditions that involve eosinophilic inflammation. They are commonly found in patients with asthma, allergic rhinitis, and eosinophilic esophagitis. In addition, they can be present in parasitic infections such as schistosomiasis and ascariasis.
Diagnosis[edit | edit source]
Charcot-Leyden crystals are identified through microscopic examination of samples such as sputum, stool, or tissue biopsy. Their presence can help support the diagnosis of conditions associated with eosinophilia.
Treatment[edit | edit source]
The treatment of conditions associated with Charcot-Leyden crystals involves managing the underlying cause of eosinophilia. This may include corticosteroids for asthma or antiparasitic drugs for parasitic infections.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD